Global Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Forecast 2024-2030- Product Image

Sale

Global Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Forecast 2024-2030

Report
185 Pages
May 2024
Region: Global
360iResearch™
ID: 5674447

UP TO €643EUR$675USD£552GBP OFF until Dec 31^st 2024

The Particle Therapy Market size was estimated at USD 772.41 million in 2023, USD 831.50 million in 2024, and is expected to grow at a CAGR of 7.94% to reach USD 1,318.87 million by 2030.

The particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth.

In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.

Regional Insights

In America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique.

Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

Market Trends by Segment

Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care

Industry Insights

Market Dynamics
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
Market Share Analysis
Strategy Analysis and Recommendations

Recent Developments

IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership

IBA International and PARTICLE (Particle Therapy Interuniversity Center Leuven) have established a Research Partnership to develop ConformalFLASH in the context of Particle Therapy. This collaboration signifies another significant milestone in bringing FLASH therapy to patients in the clinic.

P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

P-Cure Ltd has obtained FDA clearance for its Adaptive Proton Therapy Solution in the USA. This solution represents the FDA-approved methodology for patient-ready cancer treatment. This FDA clearance represents a significant milestone in expanding the clinical benefits of proton therapy to medical facilities globally while also providing a cost-effective option for existing oncology centers.

Terapet raises CHF 2.3 million for its next-generation cancer treatment technology

CERN secured CHF 2.3 million in funding to develop particle therapy technology to enhance cancer treatments by delivering radiation doses with unparalleled precision and minimizing damage to healthy tissue. With this significant investment and the promising development of Qualγscan, Terapet is poised to make significant advancements in particle therapy technology, revolutionizing cancer treatment and improving patient outcomes.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd.

This research report offers invaluable insights into various crucial aspects of the Particle Therapy Market:

Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current market size and projected growth?
Which products, segments, applications, and regions offer promising investment opportunities?
What are the prevailing technology trends and regulatory frameworks?
What is the market share and positioning of the leading vendors?
What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advanced therapies in cancer treatment
5.1.1.2. Rise in adoption of particle therapy in clinical trials
5.1.1.3. Growing number of particle therapy centers worldwide
5.1.2. Restraints
5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
5.1.3. Opportunities
5.1.3.1. Ongoing proton therapy research programs
5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
5.1.4. Challenges
5.1.4.1. Risk associated with the particle therapy radiation exposure
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Particle Therapy Market, by Therapy Type

6.1. Introduction
6.2. Heavy Ion Therapy
6.3. Proton Therapy

7. Particle Therapy Market, by Component

7.1. Introduction
7.2. Product
7.3. Service

8. Particle Therapy Market, by Configuration

8.1. Introduction
8.2. Multi-room System
8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

9.1. Introduction
9.2. Breast Cancer
9.3. Head & Neck Cancer
9.4. Lung Cancer
9.5. Pediatric Cancer
9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Particle Therapy Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
14.3.2. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
14.3.3. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio

List of Figures

FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 90. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 91. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 92. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 93. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 96. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 97. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 98. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 99. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 102. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 103. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 104. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 105. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 108. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 109. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 110. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 111. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 154. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 155. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 156. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 157. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 160. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 161. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 162. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 163. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 164. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 165. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 166. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 167. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 168. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 169. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 172. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 173. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 174. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 175. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 178. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 189. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 190. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 191. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 192. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 193. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 196. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 197. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 198. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 199. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 202. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 203. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 204. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 205. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 214. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 215. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 216. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 217. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 226. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 227. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 228. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 229. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 238. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 239. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 240. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 241. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 249. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 250. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 251. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 252. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 253. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 262. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 263. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 264. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 265. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 268. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 269. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 270. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 271. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 274. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 275. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 276. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 277. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 299. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 300. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 301. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 302. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 303. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 306. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 307. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 308. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 309. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 310. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 311. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 312. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 313. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 314. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 315. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 318. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 319. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 320. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 321. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 324. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 325. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 326. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 327. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 330. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 331. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 332. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 333. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 334. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 335. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 336. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 337. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 338. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 339. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 342. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 343. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 344. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 345. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 346. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 347. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 348. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 349. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 350. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 351. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
TABLE 354. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
TABLE 355. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 356. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 357. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 358. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 359. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 360. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 361. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 362. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 363. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 364. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLIO

Companies Mentioned

Advanced Oncotherapy plc
B dot Medical Inc.
Best Particle Therapy, Inc.
BioSig Technologies Inc.
Covenant Health
Danfysik A/S
Elekta AB
Hitachi, Ltd.
IBA International
Koninklijke Philips N.V.
Mevion Medical Systems
Mitsubishi Electric Corporation
New Mexico Cancer Center
Optivus Proton Therapy, Inc.
P-Cure Ltd
ProTom International
Provision Healthcare, LLC
PTW Freiburg GmbH
SAH Global LLC
Shanghai APACTRON Particle Equipment Co., Ltd.
Siemens Healthineers GmbH
Stantec Inc.
Sumitomo Heavy Industries, Ltd.
Toshiba Medical Systems Corporation
Xstrahl Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	May 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 831.5 Million
Forecasted Market Value ( USD ) by 2030	$ 1318.87 Million
Compound Annual Growth Rate	7.9%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Month

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3216EUR$3,374USD£2,759GBP €3573EUR$3,749USD£3,065GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4074EUR$4,274USD£3,495GBP €4526EUR$4,749USD£3,883GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4931EUR$5,174USD£4,230GBP €5479EUR$5,749USD£4,700GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5789EUR$6,074USD£4,966GBP €6433EUR$6,749USD£5,518GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Month	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one month.	This is an enterprise license, allowing all employees within your organization access to the product.	€8339EUR$8,749USD£7,153GBP

Regional Insights

Market Trends by Segment

Industry Insights

Recent Developments

IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership

P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

Terapet raises CHF 2.3 million for its next-generation cancer treatment technology

Key Company Profiles

This research report offers invaluable insights into various crucial aspects of the Particle Therapy Market:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Particle Therapy Global Market Report 2024

Particle Therapy - Global Strategic Business Report

Global Particle Therapy Market: Focus on Products and Services, Application, Cancer Type, Type, System, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033

Global Particle Therapy Market Report and Forecast 2024-2032

Particle Therapy System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type